Calando Pharmaceuticals / Oxford University Press / /
Country
Germany / /
Facility
Max-Planck Institute / National Cancer Institute / Purdue University’s Cancer Research Center / University of Massachusetts / California Institute of Technology / /
IndustryTerm
sulfur-containing chemical / cancer therapy / Cancer Therapies / nanoparticle technology / important tool / treatment of human ailments / particularly cancer / treatment of cancer / therapy for cancer / manufacturing / chemical modifications / /
MedicalCondition
reason tumors / metastasis / human tumor / common extracranial solid tumor / neuroblastoma / hepatitis B / siRNA inside cancer / newly developing blood vessels surrounding tumors / metastatic Ewing's sarcoma / human breast cancer / breast cancer / leukemia / tumor / cancer / nasopharyngeal carcinoma / tumors / disease / better target cancer / sarcoma / targeted cancer / AIDS / chronic diseases / inflammation / /
MedicalTreatment
cancer therapy / Gene Therapy / /
Organization
National Cancer Institute / California Institute of Technology / University of Massachusetts / NCI Alliance for Nanotechnology / Purdue University’s Cancer Research Center / Purdue University / Max-Planck Institute for Biophysical Chemistry / U.S. Food and Drug Administration / Oxford University / /
Person
Andrew Hamilton / Mark Davis / Thomas Tuschl / Vincent Rotello / Peixuan Guo / Derek Bartlett / David Baulcombe / Martin Woodle / Joe Alper Selected References Devi / /
Position
specific messenger / founder / chief scientific officer / /
Product
Investigational New Drug / folic acid / glycine / /
Nanomonthly-Aug06_082506.qxp